Isomorphic Labs' chief executive, Sir Demis Hassabis, delivering his Nobel Prize lecture in 2024. Alphabet-backed start-up Isomorphic Labs has added to the lustre attached to its AI-powered drug ...

Monday - Friday, 08:00 - 11:00 CET | 14:00 - 17:00 HK/SG Max Jaderberg, President of Isomorphic Labs, speaks to CNBC's Ritika Gupta at London Tech Week to discuss the advancement of AI in medicine Got ...

After breaking his leg in a backstage skateboarding accident in April, Billy Strings returned to the stage Sunday night (May 31) at Les Claypool’s concert in Detroit. The celebrated bluegrass musician ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Physicists may have uncovered a surprising new clue that string theory—the idea that the universe is built from unimaginably tiny vibrating strings—could be more than just a mathematical fantasy.

The race to use artificial intelligence for designing medicines is rapidly becoming one of the most expensive and closely watched bets in technology and biotech. On 12 May 2026, Isomorphic Labs ...

Isomorphic Labs, an AI drug discovery and development company, raised $2.1 billion in a Series B funding round led by Thrive Capital. The raise was also backed by existing investors Alphabet and GV ...

If you could take an apple and break it into smaller and smaller parts, you would find molecules, then atoms, followed by subatomic particles like protons and the quarks and gluons that make them up.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Demis Hassabis, CEO of Isomorphic and Google DeepMind Isomorphic, which formed as an ...

Isomorphic Labs, the AI-first drug discovery company founded by Demis Hassabis, has raised $2.1 billion in a Series B funding round as competition intensifies around artificial intelligence-driven ...

The organisation plans to use the investment as a means of accelerating the application of its AI model at scale. AI-powered drug design and development company Isomorphic Labs has announced a raise ...